Literature DB >> 25448632

Identification of proteins in Streptococcus pneumoniae by reverse vaccinology and genetic diversity of these proteins in clinical isolates.

Ana Paula Corrêa Argondizzo1, Fabio Faria da Mota, Cristiane Pinheiro Pestana, Joice Neves Reis, Antonio Basílio de Miranda, Ricardo Galler, Marco Alberto Medeiros.   

Abstract

Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide. Virulence-associated proteins common and conserved among all capsular types now represent the best strategy to combat pneumococcal infections. Our aim was to identify conserved targets in pneumococci that showed positive prediction for lipoprotein and extracellular subcellular location using bioinformatics programs and verify the distribution and the degree of conservation of these targets in pneumococci. These targets can be considered potential vaccine candidate to be evaluated in the future. A set of 13 targets were analyzed and confirmed the presence in all pneumococci tested. These 13 genes were highly conserved showing around >96 % of amino acid and nucleotide identity, but they were also present and show high identity in the closely related species Streptococcus mitis, Streptococcus oralis, and Streptococcus pseudopneumoniae. S. oralis clusters away from S. pneumoniae, while S. pseudopneumoniae and S. mitis cluster closer. The divergence between the selected targets was too small to be observed consistently in phylogenetic groups between the analyzed genomes of S. pneumoniae. The proteins analyzed fulfill two of the initial criteria of a vaccine candidate: targets are present in a variety of different pneumococci strains including different serotypes and are conserved among the samples evaluated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25448632     DOI: 10.1007/s12010-014-1375-3

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  3 in total

1.  Immunoproteomics to identify Staphylococcus aureus antigens expressed in bovine milk during mastitis.

Authors:  N Misra; X Pu; D N Holt; M A McGuire; J K Tinker
Journal:  J Dairy Sci       Date:  2018-05-03       Impact factor: 4.034

2.  Identification of Novel Vaccine Candidates against Campylobacter through Reverse Vaccinology.

Authors:  Marine Meunier; Muriel Guyard-Nicodème; Edouard Hirchaud; Alberto Parra; Marianne Chemaly; Daniel Dory
Journal:  J Immunol Res       Date:  2016-06-16       Impact factor: 4.818

3.  Towards Reverse Vaccinology for Bovine TB: High Throughput Expression of Full Length Recombinant Mycobacterium bovis Proteins.

Authors:  Deepa Paliwal; Michelle Thom; Areej Hussein; Divyashree Ravishankar; Alex Wilkes; Bryan Charleston; Ian M Jones
Journal:  Front Mol Biosci       Date:  2022-08-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.